Treace Medical Concepts, Inc.
TMCI
$6.72
-$0.26-3.73%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.86% | 10.44% | 10.62% | 5.96% | 21.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.86% | 10.44% | 10.62% | 5.96% | 21.12% |
| Cost of Revenue | 5.43% | 15.36% | 11.95% | 14.41% | 25.97% |
| Gross Profit | 2.23% | 9.33% | 10.29% | 4.07% | 19.98% |
| SG&A Expenses | -5.08% | -5.44% | 0.16% | 18.48% | 22.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.75% | -0.20% | 2.81% | 19.69% | 25.20% |
| Operating Income | 17.85% | 97.77% | 15.06% | -63.82% | -37.69% |
| Income Before Tax | 14.75% | 92.02% | 12.33% | -72.81% | -38.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.75% | 92.02% | 12.33% | -72.81% | -38.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.75% | 92.02% | 12.33% | -72.81% | -38.81% |
| EBIT | 17.85% | 97.77% | 15.06% | -63.82% | -37.69% |
| EBITDA | 23.08% | 119.70% | 20.16% | -61.13% | -32.73% |
| EPS Basic | 15.92% | 92.14% | 13.28% | -70.89% | -31.91% |
| Normalized Basic EPS | 15.93% | 92.92% | 13.27% | -70.94% | -31.91% |
| EPS Diluted | 15.92% | 89.59% | 13.28% | -70.89% | -31.91% |
| Normalized Diluted EPS | 15.93% | 92.92% | 13.27% | -70.94% | -31.91% |
| Average Basic Shares Outstanding | 1.41% | 1.04% | 1.08% | 1.14% | 5.23% |
| Average Diluted Shares Outstanding | 1.41% | 1.04% | 1.08% | 1.14% | 5.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |